• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DarioHealth, Glytec ink joint marketing deal

March 27, 2019 By Fink Densford

DarioHealth, Glytec

DarioHealth (NSDQ:DRIO) said today it inked a joint marketing agreement with Glytec through which DarioHealth’s smart glucose meter will be able to transmit information to Glytec’s Glucommander Outpatient software.

Israel-based DarioHealth said that blood glucose data from its Dario Blood Glucose Monitoring System will now be imported into the Glucommander Outpatient for use in conjunction with other clinical data to create personalized insulin dose recommendations.

“The Dario Blood Glucose Monitoring System is growing in popularity among people with both Type 1 and Type 2 diabetes, and we are pleased to be able to add DarioHealth to our best-in-class network of connected device partners. Glytec doesn’t make devices, we make devices better by adding the missing element, which is insulin titration. There is little that can be done to achieve and sustain significant A1c improvements with data alone, but by making that data actionable and making timely insulin dose adjustments, we see average reductions in A1c of 2.7% points and higher over 12 months,” Glytec prez & CEO Bob Leonard said in a prepared statement.

DarioHealth touted that its Blood Glucose Monitoring System features an all-in-one smart glucose meter, a personal diabetes progress monitor, on-demand data sharing, emergency hypoglycemia alerts and a GPS locator and a carbohydrate counting tool.

“Glytec will benefit from real-time, accurate blood glucose data to provide insulin titration decision support, and we are convinced that the Dario Blood Glucose Monitoring System will be a more complete solution when paired with Glucommander Outpatient. We believe that people with diabetes need this synergy to be most successful in managing their diabetes,” DarioHealth CEO Erez Raphael said in a press release.

In January, DarioHealth said that it inked a deal with healthcare products provider Better Living Now for the distribution of its blood glucose monitoring system and the DarioEngage digital health program.

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: dariohealth, Glytec

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS